Skip to main content↵ Go to site menu↵ Jump to page footer↵
Exception occured while executing the controller. Check error logs for details.
SPECTRE
Explore UTMB
  • Health Care
  • Education
  • Research
  • UTMB Support Areas
  • Giving
  • Contacts
  • Alerts
  • Search
UTMB Health
  • SPECTRE
    • Home
    • About Us
    • Our Team
    • Partners
    • Contact Us
    • Job Postings
    • Reports
  • News & Events
    • Newsletter
    • All News
    • Events
    • Publications
    • CTD-SPECTRE 2nd Annual Symposium
  • Education
    • Education & Training
    • In-person Training  
    • Webinars and Speaker Request 
    • Resource Index
    • Contact the Education Department
  • Biocontainment Care Unit
    • BCU Home
    • Facilities
    • BCU Team Training Program
  • Research
    • Research Support Home
    • Biorespository
  • Coordination  
Menu
  • Ghana declares first-ever outbreak of Marburg virus disease

    July 21, 2022 • 7:00 a.m. by World Health Organization

    Accra/Brazzaville - Ghana has announced the country’s first outbreak of Marburg virus disease, after a World Health Organization (WHO) Collaborating Centre laboratory confirmed earlier results.

  • Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

    July 7, 2022 • 8:00 a.m.

    Cameron R. Wolfe, et al. - The Lancet Respiratory Medicine, May 23, 2022

  • Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

    July 7, 2022 • 7:00 a.m.

    Andre C. Kalil, et al. - The Lancet Respiratory Medicine, October 18, 2021

  • Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial

    July 7, 2022 • 7:00 a.m.

    Corri B. Levine, et al. - Health Security, May 31, 2022

  • Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response

    July 7, 2022 • 7:00 a.m.

    Jonathan D. Grein, et al. - Health Security, May 31, 2022

  • Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization

    July 7, 2022 • 7:00 a.m.

    Clinical Infectious Disease, August 19, 2021

  • Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

    July 7, 2022 • 7:00 a.m.

    Andre C. Kalil, et al. - New England Journal of Medicine, March 4, 2021

  • Synthetic proteins for COVID-19 diagnostics

    July 7, 2022 • 7:00 a.m.

    Catherine H. Schein, et al. - Peptides, September, 2021

  • UTMB’s new Biocontainment Care Unit is prepared for the next Ebola Outbreak

    July 7, 2022 • 7:00 a.m.

    Shanley Pierce - TMC News, May 10, 2019

  • Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators

    July 2, 2022 • 7:00 a.m.

    Nathen E. Bopp, et al. - Applied Biosafety, September 1, 2020

  • Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines

    December 12, 2017 • 6:00 p.m.

    Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines

    Levine, C. B., Bayle, J., Biourge, V. & Wakshlag, J. J., Dec 13 2017, In: BMC Veterinary Research. 13, 1, 388.

    Research output: Contribution to journal › Article › peer-review

  • The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines

    May 31, 2016 • 7:00 p.m.

    The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines

    Loftus, J. P., Cavatorta, D., Bushey, J. J., Levine, C. B., Sevier, C. S. & Wakshlag, J. J., Jun 1 2016, In: Veterinary and Comparative Oncology. 14, 2, p. e17-e30

    Research output: Contribution to journal › Article › peer-review

  • Increasing body condition score is positively associated interleukin-6 and monocyte chemoattractant protein-1 in Labrador retrievers

    October 14, 2015 • 7:00 p.m.

    Increasing body condition score is positively associated interleukin-6 and monocyte chemoattractant protein-1 in Labrador retrievers

    Frank, L., Mann, S., Levine, C. B., Cummings, B. P. & Wakshlag, J. J., Oct 15 2015, In: Veterinary Immunology and Immunopathology. 167, 3-4, p. 104-109 6 p.

    Research output: Contribution to journal › Article › peer-review

  • «
  • 1
  • …
  • 10
  • 11
  • 12
 See All News
Navigate
  • SPECTRE
    • Home
    • About Us
    • Our Team
    • Partners
    • Contact Us
    • Job Postings
    • Reports
  • News & Events
    • Newsletter
    • All News
    • Events
    • Publications
    • CTD-SPECTRE 2nd Annual Symposium
  • Education
    • Education & Training
    • In-person Training  
    • Webinars and Speaker Request 
    • Resource Index
    • Contact the Education Department
  • Biocontainment Care Unit
    • BCU Home
    • Facilities
    • BCU Team Training Program
  • Research
    • Research Support Home
    • Biorespository
  • Coordination  
Explore UTMB
  • Health Care
  • Education
  • Research
  • UTMB Support Areas
  • Giving
  • Contacts
  • Alerts
Back to top
UTMB.eduUTMBHealth.comMaps & DirectionsPrivacy Policy & Required Links
© The University of Texas Medical Branch at Galveston   Member, Texas Medical Center®
UTMB Web:  WWW Login | Intranet Login
UTMB Health